Abstract
Clinical study of bilateral repetitive transcranial magnetic stimulation combined with electromyographic biofeedback in the treatment of dysphagia after stroke
  
DOI:
EN KeyWords: bilateral repetitive transcranial magnetic stimulation  electromyographic biofeedback  stroke  dysphagia
Fund Project:湖北省自然科学基金项目(2021CFB359);湖北省卫健委中医面上项目(ZY2021M101)
作者单位
吴晶 湖北省中西医结合医院康复医学中心武汉 430015 
张伟 湖北省中西医结合医院康复医学中心武汉 430015 
陈焱强 湖北省中西医结合医院康复医学中心武汉 430015 
徐婷 湖北省中西医结合医院康复医学中心武汉 430015 
文妮 湖北省中西医结合医院康复医学中心武汉 430015 
段璨 湖北省中西医结合医院康复医学中心武汉 430015 
李正良 湖北省中西医结合医院康复医学中心武汉 430015 
郑婵娟 湖北省中西医结合医院康复医学中心武汉 430015 
View Counts: 4047
PDF Download Counts: 6220
EN Abstract:
  Objective: To observe the clinical efficacy of low-frequency repetitive transcranial magnetic stimulation (rTMS) acting on the healthy hemisphere and high-frequency rTMS acting on the affected hemisphere combined with electromyographic (EMG) biofeedback therapy in patients with post-stroke dysphagia (PSD). Methods: A total of 100 stroke patients were randomly divided into the control group and the experimental group with 50 patients in each group. Both groups were all treated with routine medication and swallowing rehabilitation training, the control group was treated with EMG biofeedback training and sham rTMS, and the experimental group was treated additionally with rTMS and EMG biofeedback training. The low-frequency of rTMS acting on the healthy hemisphere was 1 Hz, and the high-frequency of rTMS acting on the affected hemisphere was 10 Hz. The swallowing function of patients was evaluated by the water swallowing test, and the Rosenbek Penetration-Aspiration Scale (PAS) and the functional oral intake scale (FOIS). The swallowing quality of life scale (SWAL-QOL) was used to evaluate the patients’ swallowing quality of life. The clinical efficacy of the two groups was evaluated at the end of treatment. Results: After 2 weeks of treatment regimens, the total effective rate was 93.88% in the experimental group, and 73.47% in the control group (P<0.05). The scores of swallowing function and quality of life in the two groups were significantly improved as compared with those before treatment (P<0.05). The scores of PAS, FOIS and SWAL-QOL in the experimental group were better than those in the control group (P<0.05). The water swallowing test in the experimental group was better than in the control group after treatment. Conclusion: The rTMS acting on the bilateral brain combined with EMG biofeedback can improve the swallowing function and swallowing quality of life of stroke patients.
查看全文   Download PDF Reader  HTML Full Text
Close
本刊微信二维码